Amundi Asset Management US’s Axonics, Inc. Common Stock AXNX Stock Holding History

Amundi Asset Management US’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$12.7M	Buy	+211,526	New	+$11.5M	0.01%	775

Other funds holding AXNX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Amundi Asset Management US's AXNX Position: Q1 2021 in Review

Amundi Asset Management US opened a new position in Axonics, Inc. Common Stock (AXNX) in Q1 2021: 211,526 shares worth $12.7M. The stake represents 0.01% of the portfolio and ranks #775 among its holdings.

160 funds tracked by Wall St. Rank hold AXNX as of Q1 2021.

Amundi Asset Management US held 211,526 shares of Axonics, Inc. Common Stock worth $12.7M as of Q1 2021.
Axonics, Inc. Common Stock was a new Amundi Asset Management US position in Q1 2021.
Axonics, Inc. Common Stock made up 0.01% of Amundi Asset Management US's portfolio in Q1 2021, its #775 holding.
160 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.